How Scrubbed Helps Jaguar Health Navigate Accounting Complexities in Life Sciences

The Ink is Final: Why Technical Accounting Can’t Wait Until the Deal is Done

At A Glance Technical accounting review shouldn’t be a post-mortem. Whether it’s a financing round, a complex revenue contract, a licensing agreement, or other significant contracts, the accounting outcome is locked the moment the agreements are signed. A single clause on down-round protection, redemption, or variable share settlement can reclassify a capital injection as a liability under ASC 480 or ASC 815. For SEC-listed companies relying on those proceeds to meet equity thresholds, review timing determines the outcome. In SEC reporting and technical accounting, there is a distinct line between what we can advise on and what we simply have to record. That line is a signature. A few years ago, we were working with a publicly listed client in the life sciences sector. Like many companies in this industry, their core challenge was capital. They were deep into Research & Development, which meant they were pre-revenue but burning through cash. To fuel their operations, they were actively engaging in complex financing transactions. But as a publicly traded company on the US SEC, their pressure was both operational and regulatory. To maintain their listing, they were required to meet the equity threshold requirement. This is where the issue became clear. The Risks of Addressing Accounting After the Deal The client was finalizing their financing contracts, signing on the dotted line, and then handing the agreements over to our technical accounting team to record. Under US GAAP, financing transactions are not always classified as equity. Depending on the nuance of specific clauses, such as down-round protections, redemption features, or settlement in a variable number of shares, a capital injection intended to bolster the balance sheet can inadvertently trigger classification as mezzanine equity or a liability under ASC 480 or ASC 815. By the time the contracts reached my desk, the agreements had already been finalized. If the legal terms dictated a liability classification, the accounting treatment was path-dependent, meaning the legal form had already dictated the financial substance. For a company relying on that specific transaction to boost its equity and maintain its SEC listing, an unexpected liability classification poses a significant financial and regulatory risk. They were risking delisting not due to a lack of capital, but due to the specific syntax of their contracts. The issue wasn’t the accounting itself, but when the accounting was being applied: they were bringing us in too late in the process. Related: How Biotech Firms Prepare Financials for IPO Shifting Accounting Earlier in the Process We raised this issue with the management team and suggested a fundamental change to the workflow: shifting our involvement to before the contracts were finalized. By reviewing the agreements while they were still in draft form, we transformed our role from reactive reporters to proactive advisors. Instead of assessing the impact after the fact, we identified the exact triggers, the “indexation” or “settlement” traps, that would dictate equity vs. liability treatment. This allowed their leadership team to make an informed, strategic judgment. They could choose to tweak the key terms of their agreements to ensure the final contracts aligned with their financial goals and regulatory compliance. Of course, moving up the timeline introduced a new pressure: speed. Draft contracts in the middle of a financing round require immediate turnarounds. But because we had been working with this client since 2020, originally helping them remediate material weaknesses and control deficiencies reported by their auditors, we knew their business inside and out. We understood their historical transactions, their operational goals, and the specific mechanics of their industry. That deep familiarity allowed us to execute complex technical assessments rapidly, without slowing down their deal momentum. Designing the Future, Not Recording the Past Today, that client remains successfully listed. The control deficiencies that plagued their early audits are a thing of the past, and their Internal Controls over Financial Reporting are clean. When I look back on the evolution of this engagement, it reinforces a fundamental truth about our profession. Trust is not built by simply fulfilling the scope of work. It’s built by identifying the root cause of a client’s anxiety and taking ownership of the outcome. When a client views you as an outsourced vendor, you are just there to record their history. But when you operate as an integrated partner, you help them design their future. Compliance and technical accounting are most effective when addressed early in the process. When positioned correctly, they are the architectural foundation that keeps a growing business secure. Related: Scaling Financial Operations in Life Sciences and Biotech with Fractional Teams Key Takeaways Financing transactions are not automatically equity. Specific clauses such as down-round protections, redemption features, or variable share settlement can trigger liability classification under ASC 480 or ASC 815.For SEC-listed companies, an unexpected liability classification can put exchange listing requirements at risk. The exposure comes not from a lack of capital but from the syntax of the contracts.Once contracts are signed, technical accounting becomes path-dependent. The legal form has already dictated the financial substance. Reviewing agreements in draft form lets leadership adjust key provisions before execution, aligning the final contract with financial goals and regulatory requirements. The earlier technical accounting enters the process, the more strategic its value. Late involvement records history. Early involvement shapes the future.